Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS

Therapuetic Areas:Other
Age Range:18 - Any
Start Date:February 2015
End Date:April 2020
Contact:Jennifer Lanz, MSN

Use our guide to learn which trials are right for you!

Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle. Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS

This study investigates the mechanism by which kidney dysfunction perpetuates inflammation,
immunosuppression, and catabolism (PICS) in chronic critical illness. The investigators will
test the hypothesis that persistent kidney dysfunction in sepsis associated by chronic
critical illness contributes to decreased survival through the development of PICS. In
chronic critical illness, the persistence of the inflammatory state may lead to capillary
rarefication in the kidney causing accelerated chronic kidney disease. Progression of chronic
kidney disease during chronic critical illness can drive PICS. Indeed, many of the features
of chronic critical illness are consistent with the protein-energy malnutrition and muscle
wasting associated with chronic kidney disease. Thus, the kidney can play a contributory role
in chronic critical illness and PICS.

The main goal of this project is to measure kidney filtration function at day 14 or the day
of discharge from hospital (whichever occurs first), in order to determine the presence and
magnitude of persistent kidney dysfunction after sepsis episode and to longitudinally assess
further decline of kidney function at one year follow-up. The measure of the glomerular
filtration rate (GRF) in patients with chronic critical illness and controls (sepsis patients
discharged from ICU before day 14) will be used to determine to what degree of kidney
dysfunction contributes to decreased survival and increase in chronic kidney disease at year
one after sepsis onset.

One and/or all of the three ways for GFR assessment will be used, both at approximately day
14 or approximately at the day of discharge from the ICU and at the one year follow up :

1. Determine clearance of Iohexol from blood after Iohexol injection and/or

2. Determine apperance of Iohexol in urine after Iohexol injection (this would be the same
injection as in one, and would not require two injections) and/or

3. A timed urine collection to determine clearance of urea and creatinine and/or

4. Estimated GFR using calculations with serum creatinine and cystatin C,

This will provide an opportunity to validate the different measurements.

Inclusion Criteria:

- Presence in the surgery or trauma ICU

- Age of ≥18 years

- Entrance into our sepsis protocol

- Ability to obtain informed consent.

Exclusion Criteria:

- Expected lifespan of the patient is less than 3 months due to severe pre-existing
comorbidities (ex. recurrent, advanced or metastatic cancer)

- Severe traumatic brain injury (evidence of neurologic injury on CT scan and a GCS <8)

- Refractory shock (i.e., patients who die within 12 hours)

- Uncontrollable source of sepsis (e.g., irreversible disease state such as unresectable
dead bowel)

- Patient or patient's family are not committed to aggressive management of the
patient's condition and/or the patient has a DNR/DNI on file.

- Severe CHF (NY Heart Association Class IV)

- Child-Pugh C liver disease or pre-liver transplant.

- Known HIV infection with CD4 count <200 cells/mm3

- Organ transplant recipient on immunosuppressive agents

- Known pregnancy and mother's that are breastfeeding

- Prisoners

- Institutionalized patients

- Inability to obtain informed consent.

- Chemotherapy or radiotherapy within 30 days prior to sepsis.

- End stage renal disease on admission.
We found this trial at
Gainesville, Florida 32610
Phone: 352-273-5497
Gainesville, FL
Click here to add this to my saved trials